74 related articles for article (PubMed ID: 25057941)
1. [Role of COX-2/PGE2/EP4 Axis-induced Macrophage Functional Activation
in NSCLC Development].
Zhao J; Zhu Q; Zhang Y; Li G; Zhang Y; Li F; Bian L
Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):245-256. PubMed ID: 38769827
[TBL] [Abstract][Full Text] [Related]
2. The Regulatory Role of
Chen F; Zheng Y; Zhou H; Li C
Cancer Biother Radiopharm; 2024 Apr; 39(3):211-222. PubMed ID: 35802495
[No Abstract] [Full Text] [Related]
3. Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer.
Jabbarzadeh Kaboli P; Chen HF; Babaeizad A; Roustai Geraylow K; Yamaguchi H; Hung MC
Cancer Lett; 2024 Apr; 588():216780. PubMed ID: 38462033
[TBL] [Abstract][Full Text] [Related]
4. MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis.
Liang H; Wang M
Onco Targets Ther; 2020; 13():2491-2510. PubMed ID: 32273721
[TBL] [Abstract][Full Text] [Related]
5. The HGF/Met Receptor Mediates Cytotoxic Effect of Bacterial Cyclodipeptides in Human Cervical Cancer Cells.
Hernández-Padilla L; Durán-Maldonado MX; Martínez-Alcantar L; Rodríguez-Zavala JS; Campos-Garcia J
Curr Cancer Drug Targets; 2024 Apr; ():. PubMed ID: 38629372
[TBL] [Abstract][Full Text] [Related]
6. Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer.
Mancini M; Gaborit N; Lindzen M; Salame TM; Dall'Ora M; Sevilla-Sharon M; Abdul-Hai A; Downward J; Yarden Y
Sci Signal; 2015 Jun; 8(379):ra53. PubMed ID: 26038598
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and predictive value of MET deregulation in non-small cell lung cancer.
Finocchiaro G; Toschi L; Gianoncelli L; Baretti M; Santoro A
Ann Transl Med; 2015 Apr; 3(6):83. PubMed ID: 25992382
[TBL] [Abstract][Full Text] [Related]
8. Syngeneic tobacco carcinogen-induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden.
Stabile LP; Kumar V; Gaither-Davis A; Huang EH; Vendetti FP; Devadassan P; Dacic S; Bao R; Steinman RA; Burns TF; Bakkenist CJ
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33351788
[TBL] [Abstract][Full Text] [Related]
9. (-)-Oleocanthal as a Dual c-MET-COX2 Inhibitor for the Control of Lung Cancer.
Siddique AB; Kilgore PCSR; Tajmim A; Singh SS; Meyer SA; Jois SD; Cvek U; Trutschl M; Sayed KAE
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32545325
[TBL] [Abstract][Full Text] [Related]
10. Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition.
Kumar G; Goldberg SN; Wang Y; Velez E; Gourevitch S; Galun E; Ahmed M
Eur Radiol; 2017 Mar; 27(3):1238-1247. PubMed ID: 27287478
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer.
Stabile LP; Lyker JS; Land SR; Dacic S; Zamboni BA; Siegfried JM
Carcinogenesis; 2006 Aug; 27(8):1547-55. PubMed ID: 16513678
[TBL] [Abstract][Full Text] [Related]
12. Targeting the MET gene for the treatment of non-small-cell lung cancer.
Gelsomino F; Facchinetti F; Haspinger ER; Garassino MC; Trusolino L; De Braud F; Tiseo M
Crit Rev Oncol Hematol; 2014 Feb; 89(2):284-99. PubMed ID: 24355409
[TBL] [Abstract][Full Text] [Related]
13. [Research progress of HGF/MET signaling pathway in EGFR-TKI resistance
in non-small cell lung cancer].
Song S; Bi M
Zhongguo Fei Ai Za Zhi; 2014 Oct; 17(10):755-9. PubMed ID: 25342043
[TBL] [Abstract][Full Text] [Related]
14. Co-targeting c-Met and COX-2 leads to enhanced inhibition of lung tumorigenesis in a murine model with heightened airway HGF.
Stabile LP; Rothstein ME; Gubish CT; Cunningham DE; Lee N; Siegfried JM
J Thorac Oncol; 2014 Sep; 9(9):1285-93. PubMed ID: 25057941
[TBL] [Abstract][Full Text] [Related]
15. Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non small-cell lung cancer.
Siegfried JM; Gubish CT; Rothstein ME; Queiroz de Oliveira PE; Stabile LP
Mol Pharmacol; 2007 Sep; 72(3):769-79. PubMed ID: 17550984
[TBL] [Abstract][Full Text] [Related]
16. Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.
Navab R; Liu J; Seiden-Long I; Shih W; Li M; Bandarchi B; Chen Y; Lau D; Zu YF; Cescon D; Zhu CQ; Organ S; Ibrahimov E; Ohanessian D; Tsao MS
Neoplasia; 2009 Dec; 11(12):1292-300. PubMed ID: 20019837
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
